ESC Professional Premium Access

A genetic polymorphism on chromosome 4q25 (rs17570669_T) may predict atrial fibrillation recurrence after successful electrical cardioversion

Congress Presentation

About the speaker

Professor Taner Ulus

Eskisehir Osmangazi University, Eskisehir (Türkiye)
1 follower

5 more presentations in this session

Efficacy and safety of antiarrhythmic drugs for pharmacological cardioversion of atrial fibrillation depending on gender: a subanalysis of CANT II Study

Speaker: Associate Professor M. Wybraniec (Katowice, PL)


Intravenous infusion of potassium/magnesium solution for the treatment of postoperative atrial fibrillation after coronary artery bypass graft: a randomized, double-blinded, parallel controlled trial

Speaker: Doctor F. Masoudkabir (Tehran, IR)


Efficacy of bepridil as a periprocedural support drug in atrial fibrillation patients with left ventricular systolic dysfunction undergoing catheter ablation

Speaker: Mr K. Okabe (Fukuoka, JP)


Development of an in vitro platform for transesophageal echocardiographic and color Doppler hemodynamic assessments of left atrial appendage occlusion devices

Speaker: Mr Z. Zhong (Munich, DE)


Persistence to edoxaban treatment in patients with atrial fibrillation: Analysis from the Global ETNA-AF program

Speaker: Doctor I. Diemberger (Bologna, IT)


Access the full session

Cardioversion, antiarrhythmics and antithrombotic management of atrial fibrillation

Speakers: Professor T. Ulus, Associate Professor M. Wybraniec, Doctor F. Masoudkabir, Mr K. Okabe, Mr Z. Zhong...

About the event


ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb